3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
NIH
1
Study Type
Observational
1
Interventional
1
Sponsor
Conditions
Diabetes Mellitus
3
Urinary Bladder Neoplasms
2
Diabetes Mellitus, Type 2
2
Pancreatic Neoplasms
1
Neoplasms
1
Metabolic Syndrome
1
Inflammation
1
Hypogonadism
1
Interventions
Surgical Procedures, Operative
2
Blood Specimen Collection
2
ziprasidone
1
semaglutide
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Zolpidem
1
Weights and Measures
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Topiramate
1
Tobramycin
1
Tirzepatide
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Radiotherapy
1
Qsymia
1
Piperacillin, Tazobactam Drug Combination
1
Pioglitazone
1
Phentermine
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Neoadjuvant Therapy
1
Naltrexone
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Inflammation
×
Pioglitazone
×
Clear all
NCT00743327
2012-08-06
ADT
National Institutes of Health Clinical Center (CC)
Terminated
1 enrolled